Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 133,334 shares at $30.19 ($4.3M) on 2025-04-28, disclosed to the SEC on 2025-04-30.
Scheduled sale ($4.3M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.19 | 41,667 | $1.3M | 29.0% |
| 2 | $30.19 | 41,667 | $1.3M | 29.0% |
| 3 | $36.39 | 50,000 | $1.8M | 42.0% |
| Total | $32.51 avg | 133,334 | $4.3M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |